Last reviewed · How we verify
NCT03731455: WIN
WISE Cortical Strip for Intraoperative Neurophysiological Monitoring
NA trial testing WISE Cortical Strip in Brain Tumor Adult in 32 participants. Completed in 20 January 2020.
20 January 2020
Quick facts
| Lead sponsor | Wise S.r.l. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 32 |
| Start date | 9 April 2019 |
| Primary completion | 20 January 2020 |
| Estimated completion | 20 January 2020 |
| Sites | 5 locations across Italy, Switzerland, Germany |
Drugs / interventions tested
- WISE Cortical Strip
Conditions studied
- Brain Tumor Adult — all drugs for Brain Tumor Adult →
- Epilepsy — all drugs for Epilepsy →
Sponsor
Wise S.r.l.
Who can join
Adults 18 to 75, any sex, with Brain Tumor Adult or Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The WIN Study is a prospective, interventional, multi-center, open-label premarket study designed to confirm the safety, performance and intended use of the WISE Cortical Strip (WCS) for CE certification purposes. Participants with documented diagnosis of epilepsy or brain tumor requiring intracranial surgery, who meet all eligibility criteria, will undergo IntraOperative Neurophysiological Monitoring (IONM) during a neurosurgical intervention with the WCS and a comparator device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03731455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brain Tumor Adult
Currently open trials in the same condition.
- NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
- NCT07225101 — Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures · Phase 4 · recruiting
- NCT07186556 — Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a · NA · recruiting
- NCT07198256 — AI-assisted Diagnosis of Malignant Brain Tumors · recruiting
- NCT07049094 — The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03731455 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wise S.r.l.
- Last refreshed: 17 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03731455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing